Loading clinical trials...
Loading clinical trials...
Phase II Study to Evaluate Efficacy and Safety of Single Weekly Administration of Bortezomib in Newly Diagnosed Multiple Myeloma
Conditions
Interventions
Bortezomib
Locations
11
United States
Little Rock VA Medical Center
Little Rock, Arkansas, United States
West Los Angeles VA Medical Center
Los Angeles, California, United States
San Francisco VA Medical Center
San Francisco, California, United States
Eastern Colorado Health Care System
Denver, Colorado, United States
West Haven VA Medical Center
West Haven, Connecticut, United States
Tampa VA Medical Center
Tampa, Florida, United States
Start Date
May 1, 2007
Primary Completion Date
March 1, 2015
Completion Date
March 1, 2015
Last Updated
September 9, 2020
NCT06679101
NCT05969860
NCT06383143
NCT06870760
NCT06057402
NCT07452198
Lead Sponsor
Boston VA Research Institute, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions